Skip to content

Cannabis: all studies

Page 82 of 294: studies 811 to 820 of 2,937, newest first. Back to the cannabis overview

Research

Cognitive outcomes associated with long-term, regular, recreational cannabis use in adults: A meta-analysis.

Experimental and Clinical Psychopharmacology August 1, 2020 M. Lovell, Jane Akhurst, C. Padgett et al.

Despite research advances, it remains unclear if long-term, regular cannabis use harms cognition once intoxication has passed. Our meta-analysis aimed to investigate the association between cognitive functioning and long-term (mean ≥2 years), regular (mean ≥4 days/week), recreational cannabis use in adults during abstinence (mean ≥12 hr). We searched PubMed, PsycINFO, CINAHL, Scopus, and...

Effects of Chronic Exposure to Low-Dose delta-9-Tetrahydrocannabinol in Adolescence and Adulthood on Serotonin/Norepinephrine Neurotransmission and Emotional Behavior

The International Journal of Neuropsychopharmacology July 23, 2020 Danilo de Gregorio, Joshua Dean Conway, Martha López-canul et al. 39 citations

BACKGROUND: Chronic exposure to the Δ9-tetrahydrocannabinol (THC), the main cannabis pharmacological component, during adolescence has been shown to be associated with an increased risk of depression and suicidality in humans. AIMS: Little is known about the impact of the long-term effects of chronic exposure to low doses of THC in adolescent compared to adult rodents. METHODS: THC (1mg/kg...

Executive Functions and Cannabis Use in Adolescents

Preprints.org July 22, 2020 Alessandro Frolli, Maria Carla Ricci, Antonella Cavallaro et al. 3 citations preprint

The developmental phase of adolescence is characterized by a multitude of neurocognitive and psychosocial changes and is therefore considered one of the most critical developmental periods of life. Experimentation on the use of substances often begins in adolescence and so does the addiction process. Most research in human subjects shows that chronic cannabis abuse is the cause of the...

The Association Between Cannabis Use and Schizophrenia: Causative or Curative? A Systematic Review

Cureus July 21, 2020 Shweta Patel, Sahar Khan, M Saipavankumar et al. 69 citations

Marijuana is one of the most abused substances in the world. Marijuana is getting legalized around the world. So, it is crucial to understand its effect on our mental health. Its impact on the schizophrenia spectrum needs our special attention. Even though marijuana has been around for a long time, its exact effects are still unknown. Schizophrenia is a chronic illness affecting approximately...

Relationship among subjective responses, flavor, and chemical composition across more than 800 commercial cannabis varieties

Journal of Cannabis Research July 17, 2020 Laura Alethia de la Fuente, Federico Zamberlán, Andrés Sánchez Ferrán et al. 30 citations

BACKGROUND: Widespread commercialization of cannabis has led to the introduction of brand names based on users' subjective experience of psychological effects and flavors, but this process has occurred in the absence of agreed standards. The objective of this work was to leverage information extracted from large databases to evaluate the consistency and validity of these subjective reports, and...

DOI: 10.1186/s42238-020-00028-y (opens in new tab) Cultivar Categorization Flavour Terpenoid +9

The short-term and long-term effects of cannabis on cognition: recent advances in the field.

Current Opinion in Psychology July 16, 2020 Emese Kroon, Lauren Kuhns, Janna Cousijn

The aim of this review is to discuss the most recent evidence for the short-term and long-term effects of cannabis on cognition. The evidence that cannabis intoxication is associated with short-term impairment across several basal cognitive domains, including learning and (episodic) memory, attentional control, and motor inhibition is increasing. However, evidence regarding the effects of...

Psicosis inducida por cannabis: características clínicas y su diferenciación con la esquizofrenia con y sin consumo de cannabis asociado

Adicciones July 14, 2020 David Rentero Martín, F. Árias, Sergio Sánchez-Romero et al. 13 citations

Cannabis use is considered an established risk factor for psychosis development. Differentiating between cannabis-induced disorders and schizophrenia is useful for prognostic and therapeutic purposes. Three inpatients groups were differentiated: cannabis-induced psychosis (CIP) (n = 69; mean age = 27.4, SD = 6.5; 82.6% males), schizophrenia with cannabis abuse or dependence (SZ + CB) (n = 57;...

DOI: 10.20882/adicciones.1251 (opens in new tab) Cannabidiol Psychosis Schizophrenia object-oriented programming Mania +3

Cannabis Use Is Associated With Increased Levels of Soluble gp130 in Schizophrenia but Not in Bipolar Disorder

Frontiers in Psychiatry July 2, 2020 Attila Szabo, Ibrahim A. Akkouh, Thor Ueland et al. 12 citations

The complex effects of plant cannabinoids on human physiology is not yet fully understood, but include a wide spectrum of effects on immune modulation. The immune system and its inflammatory effector pathways are recently emerging as possible causative factors in psychotic disorders. The present study aimed to investigate whether self-administered cannabis use was associated with changes in...

Possible therapeutic applications of cannabis in the neuropsychopharmacology field.

European Neuropsychopharmacology July 2020 Javier Fernández-Ruiz, Ismael Galve-Roperh, Onintza Sagredo et al.

Cannabis use induces a plethora of actions on the CNS via its active chemical ingredients, the so-called phytocannabinoids. These compounds have been frequently associated with the intoxicating properties of cannabis preparations. However, not all phytocannabinoids are psychotropic, and, irrespective of whether they are psychotropic or not, they have also shown numerous therapeutic properties....

Escalating low-dose Δ9 -tetrahydrocannabinol exposure during adolescence induces differential behavioral and neurochemical effects in male and female adult rats.

European Journal of Neuroscience July 2020 Nafsika Poulia, Foteini Delis, Charalampos Brakatselos et al.

Cannabinoid administration during adolescence affects various physiological processes, such as motor and affective response, cognitive-related functions and modulates neurotransmitter activity. Literature remains scant concerning the parallel examination of the effects of adolescent escalating low-dose Δ9 -tetrahydrocannabinol (Δ9 -THC) on the behavioral and plasticity profile of adult rats in...

DOI: 10.1111/ejn.14598 (opens in new tab) Full text (opens in new tab) Adult Behavioral analysis Cannabinoids Neuronal plasticity